Bank Of America Corp Cardiff Oncology, Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 53,888 shares of CRDF stock, worth $156,275. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,888
Previous 64,725
16.74%
Holding current value
$156,275
Previous $345,000
65.51%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CRDF
# of Institutions
101Shares Held
12.8MCall Options Held
823KPut Options Held
78K-
Black Rock Inc. New York, NY2.63MShares$7.62 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.14MShares$6.2 Million0.0% of portfolio
-
Assenagon Asset Management S.A.1.22MShares$3.53 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA911KShares$2.64 Million0.0% of portfolio
-
State Street Corp Boston, MA805KShares$2.33 Million0.0% of portfolio
About Cardiff Oncology, Inc.
- Ticker CRDF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,334,900
- Market Cap $126M
- Description
- Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...